rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Attention deficit hyperactivity disorder
|
|
0.810 |
GeneticVariation |
BEFREE |
Our results provide preliminary evidence for the overtransmission of the A allele at the AS3MT rs11191454 polymorphism in ADHD.
|
25461954 |
2015 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Attention deficit hyperactivity disorder
|
|
0.810 |
GeneticVariation |
GWASDB |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Attention deficit hyperactivity disorder
|
|
0.810 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASDB |
Common variants at VRK2 and TCF4 conferring risk of schizophrenia.
|
21791550 |
2011 |
rs10883795
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.
|
27922604 |
2017 |
rs11191447
|
AS3MT;BORCS7-ASMT
|
Coronary Artery Disease
|
|
0.700 |
GeneticVariation |
GWASDB |
Large-scale association analysis identifies new risk loci for coronary artery disease.
|
23202125 |
2013 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bipolar Disorder
|
|
0.700 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Child Development Disorders, Pervasive
|
|
0.700 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Major Depressive Disorder
|
|
0.700 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
rs12244388
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.
|
31268507 |
2019 |
rs12764899
|
AS3MT;BORCS7-ASMT
|
Intelligence
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
rs12764899
|
AS3MT;BORCS7-ASMT
|
RDW - Red blood cell distribution width result
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs12764899
|
AS3MT;BORCS7-ASMT
|
Red cell distribution width determination
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs12764899
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
rs12765002
|
AS3MT;BORCS7-ASMT
|
Body mass index
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs72841270
|
AS3MT;BORCS7-ASMT
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Carcinoma of bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Carcinoma of bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
rs10748835
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The combination of AS3MT haplotype 2 (AS3MT rs11191453, rs11191454, rs10748835, and rs1046778)'s high-risk haplotype (C-G-A-C, T-A-A-C, and T-G-G-T) was significantly associated with increased risk of BC.
|
29669044 |
2018 |
rs10748835
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |